Abiomed
ABMD
#1093
Rank
NZ$27.77 B
Marketcap
$615.87
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

EPS for Abiomed (ABMD)

EPS in 2022 (TTM): $9.46

According to Abiomed's latest financial reports the company's current EPS (TTM) is $9.50. In 2021 the company made an earnings per share (EPS) of $4.74 a decrease over its 2020 EPS that were of $7.19.

EPS history for Abiomed from 2013 to 2022

Annual EPS

Year EPS Change
2022 (TTM)$9.4699.82%
2021$4.74-34.16%
2020$7.19-18.05%
2019$8.789.48%
2018$8.02141.95%
2017$3.3181.42%
2016$1.83-62.83%
2015$4.91575.56%
2014$0.73125%
2013$0.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$13.90 46.26%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.33-86.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.87-109.18%๐Ÿ‡บ๐Ÿ‡ธ USA